McKesson in Talks to Acquire Florida Cancer Chain - Bloomberg
McKesson Analyst Ratings
JPMorgan Adjusts Price Target on McKesson to $661 From $656, Maintains Overweight Rating
Express News | Mckesson Corp : JP Morgan Raises Target Price to $661 From $656
McKesson (MCK) Stock Gains 18% YTD: What's Driving the Rally?
Evercore Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $630
McKesson (MCK) Receives a Buy From Evercore ISI
McKesson Corporation (MCK) Is Attracting Investor Attention: Here Is What You Should Know
McKesson's (NYSE:MCK) Soft Earnings Don't Show The Whole Picture
Argus Research Maintains McKesson(MCK.US) With Buy Rating
Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (ORIC), Aerovate Therapeutics (AVTE) and McKesson (MCK)
Argus Research Adjusts McKesson Price Target to $640 From $670
10 Health Care Stocks With Whale Alerts In Today's Session
Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY) and McKesson (MCK)
McKesson (MCK) Gets a Hold From Wells Fargo
Warner Bros, Airbnb And Monster Beverage Are Among Top 10 Large Cap Losers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
S&P 500 Stocks That Return More Capital Than Their Cost of Capital - BofA
Wells Fargo Adjusts Price Target on McKesson to $576 From $551
McKesson Corporation Just Beat EPS By 5.7%: Here's What Analysts Think Will Happen Next
Buy Rating Affirmed for McKesson With Positive Growth Outlook Despite Minor Setbacks